America's Best Nonprofits
  1. Home
  2. Medical Research
  3. Bethesda, MD
  4. Bladder Cancer Advocacy Network

Bladder Cancer Advocacy Network

Bladder Cancer Advocacy Network is ranked among medical research organizations in Bethesda, MD, with an America's Best Score of 80 out of 100, based on its 2025 Form 990.

  • Bethesda, MD
  • Tax-exempt since 2005
  • EIN: 20-2897110
bcan.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
80OF 100 Ranked in Bethesda Medical Research How this score is calculated

Organization summary

Bladder Cancer Advocacy Network is a 501(c)(3) organization, classified under Medical Research (NTEE H013). Contributions are tax-deductible.

4520 East West Hwy Ste 610, Bethesda, MD 20814-3557

Among the 7 scored medical research organizations in Bethesda, Bladder Cancer Advocacy Network holds 25.5 months of operating reserves (peer median 3.5 months), runs a typical yearly surplus of 0.4% (peers: surplus of 0.4%), and has grown spending 19.8% a year (peers: grown spending 4.1% a year).

In fiscal year 2025 it reported $6,772,678 in revenue and $7,014,426 in expenses, with contributions making up 98.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

To increase public awareness about bladder cancer, to advance bladder cancer research, and to provide educational and support services for the bladder cancer community.

Largest programs · fiscal year 2025

  • Research:bcan works to advance bladder cancer research. Recognizing the overwhelming need for research funding, bcan has engaged a new generation of researchers with the young investigator research awards, and in 2025 granted three awards. In addition, bcan supports exceptionally novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer through i… Read more

    Research:bcan works to advance bladder cancer research. Recognizing the overwhelming need for research funding, bcan has engaged a new generation of researchers with the young investigator research awards, and in 2025 granted three awards. In addition, bcan supports exceptionally novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer through its bladder cancer research innovation award, a $300,000 grants awarded over two years. Two research innovation awards were granted in 2025. A three-year career development award totaling $250,000 was initiated in 2022, supports research that translates new concepts into clinical practice. In 2025, two career development awards were issued totaling $500,000.

    $2,509,156 spent · 45.3% of program spending
  • Education and information:bcan hosts a variety of educational programs and publishes printed materials to educate those coping with a bladder cancer diagnosis. Bcan's comprehensive patient handbook, "bladder cancer basics for the newly diagnosed," has been provided to thousands of survivors, caregivers, urology practices, and cancer centers across the united states. The patient insight webinar ser… Read more

    Education and information:bcan hosts a variety of educational programs and publishes printed materials to educate those coping with a bladder cancer diagnosis. Bcan's comprehensive patient handbook, "bladder cancer basics for the newly diagnosed," has been provided to thousands of survivors, caregivers, urology practices, and cancer centers across the united states. The patient insight webinar series is an interactive program that address a variety of issues. The webinars feature top experts in their field and address patient concerns in an easy format. The survivor 2 survivor program connects newly diagnosed patients with survivors with a similar diagnosis. Bcan began offering two regional bladder cancer summits for patients and families to build and strengthen communities across the country.

    $1,548,671 spent · 28.0% of program spending
  • Think tank:the bladder cancer think tank (think tank) is the premier scientific medical symposium dedicated solely to bladder cancer. Through collaboration, urologists, oncologists, scientists, and researchers are pioneering new treatment protocols, investigating genetic expressions, and improving access to quality care for those living with the disease. The 2025 think tank was held in Washington, d.c. $623,747 spent · 11.3% of program spending
  • Walk to end bladder cancerthe walk to end bladder cancer is bcan's signature awareness event and primarily takes place in may. The walk unites bladder cancer survivors, loved ones, and the medical community to promote recognition and understanding of the disease. In 2025, bcan had over 3,500 participants register to walk across the united states excluding the participants bcan hosted virtually.adv… Read more

    Walk to end bladder cancerthe walk to end bladder cancer is bcan's signature awareness event and primarily takes place in may. The walk unites bladder cancer survivors, loved ones, and the medical community to promote recognition and understanding of the disease. In 2025, bcan had over 3,500 participants register to walk across the united states excluding the participants bcan hosted virtually.advocacyas the voice for the patient community, bcan participates in coalitions and works with other membership groups to weigh in on policy issues that directly impact those living with bladder cancer. Bcan provides the bladder cancer community with the opportunity to build connections, identify bladder cancer state and national legislative issues of importance, and learn best practices for raising awareness of bladder cancer within communities.patient and volunteer supportbcan is a grassroots organization and volunteers are an important part of patient outreach. Bcan continues to expand its volunteer programs which were formalized in 2014.- survivor 2 survivor matches newly diagnosed patients with other survivors who have had a similar experience. Through these personal connections, newly diagnosed patients learn more about living with bladder cancer and treatment options. Other programs that have been added include:- the bladder cancer call center in collaboration with the oncology social workers from cancercare.- bcan's female focus online support group meeting monthly.partners in progressbcan's partners in progress program offers companies a unique opportunity to directly engage with the bladder cancer community, patients, caregivers, and healthcare providers while showcasing their commitment to advancing care and improving lives.

    $855,411 spent · 15.4% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 79¢ went to programs, 17¢ to management and 4¢ to fundraising.

  • Programs $5,536,985
  • Management $1,221,141
  • Fundraising $256,300

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score80 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves25.5 mo; 5.8 mo in cash17.7 / 25
Financial balance (median margin)+0.4%9.4 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+19.8% / yr15 / 15
Track record21 years8.4 / 10
Debt load10.3% of assets9.9 / 10
Total80.4 → 80
Spending on programs
Not scored; America's Best needs 65%+
79%Meets

Compared with Bethesda peers

MeasureThis organizationPeer median
Operating reserves25.5 mo3.5 mo
Typical margin+0.4%+0.4%
Spending growth+19.8% / yr+4.1% / yr
Debt load10.3%18.4%

Peers: the 7 Bethesda medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$6,772,678Fiscal year 20252022: $8,907,20120222023: $5,449,89220232024: $6,370,22920242025: $6,772,6782025
Expenses$7,014,426Fiscal year 20252022: $4,075,70820222023: $5,881,72720232024: $6,105,89620242025: $7,014,4262025
Total assets$16,596,994Fiscal year 20252022: $14,357,53020222023: $14,518,46520232024: $15,785,01920242025: $16,596,9942025
Total liabilities$1,711,791Fiscal year 20252022: $1,075,54720222023: $1,026,45820232024: $1,323,05920242025: $1,711,7912025
Fiscal year ending December 2025
Revenue$6,772,678
Expenses$7,014,426
Net income−$241,748
Net assets$14,885,203

Notable sources of revenue

Percent of total revenue
Contributions$6,672,233
Program services$65,921
Investment income$306,255
Other (net)−$271,731

Assets / debt

Total assets$16,596,994
Total liabilities$1,711,791
Net assets$14,885,203

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$6,370,229
Expenses$6,105,896
Net income$264,333
Net assets$14,461,960

Notable sources of revenue

Percent of total revenue
Contributions$5,941,393
Program services$52,968
Investment income$352,510
Other (net)$23,358

Assets / debt

Total assets$15,785,019
Total liabilities$1,323,059
Net assets$14,461,960

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$5,449,892
Expenses$5,881,727
Net income−$431,835
Net assets$13,492,007

Notable sources of revenue

Percent of total revenue
Contributions$5,143,510
Program services$52,825
Investment income$251,210
Other (net)$2,347

Assets / debt

Total assets$14,518,465
Total liabilities$1,026,458
Net assets$13,492,007

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$8,907,201
Expenses$4,075,708
Net income$4,831,493
Net assets$13,281,983

Notable sources of revenue

Percent of total revenue
Contributions$8,752,305
Program services$36,265
Investment income$115,571
Other (net)$3,060

Assets / debt

Total assets$14,357,530
Total liabilities$1,075,547
Net assets$13,281,983

Compensation

Officers and key employees$302,950
Share of expenses7.4%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?